Tolemy Bio Raises €1.4 Million Pre-Seed To Build AI-Native Platform For Understanding Cellular Systems
By Amit Chowdhry ● May 12, 2026
Tolemy Bio, the London-based biology software startup, has raised €1.4 million in pre-seed funding to develop Orbit, an AI-native software platform designed to help scientists understand, predict, and direct cellular behavior. The round was led by Norrsken Evolve and Big Sur Ventures, with participation from JME Ventures, Masia, Redbus Ventures, and a group of angel investors including David Ola, Marcel Hedman, Simon Franks, and Amar Shah.